These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
218 related items for PubMed ID: 3879216
21. Further evaluation of bentiromide in the diagnosis of canine exocrine pancreatic insufficiency. Zimmer JF, Todd SE. Cornell Vet; 1985 Jul; 75(3):426-40. PubMed ID: 3874751 [Abstract] [Full Text] [Related]
22. Analysis of p-aminobenzoic acid and its metabolites in urine and plasma by ion pair HPLC in the NBT-PABA pancreatic function test. Hung CT, Perrier DG, Schicker AM, Zoest AR. Biomed Chromatogr; 1987 Feb; 2(1):13-6. PubMed ID: 3509869 [Abstract] [Full Text] [Related]
23. [Evaluation of exocrine pancreatic function by the PABA test in patients with acute pancreatitis]. Arenas M, Pérez-Mateo M, Graells ML, Sillero C, Vázquez N. Rev Esp Enferm Apar Dig; 1986 Jul; 70(1):43-8. PubMed ID: 3488572 [No Abstract] [Full Text] [Related]
24. [The exocrine pancreatic function (PABA) test and its clinical applications]. Zhou ZC, Zhang XQ, Chen MZ, Lu XH, Lu GJ, Bi ZH. Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1982 Dec; 4(6):352-7. PubMed ID: 6221814 [No Abstract] [Full Text] [Related]
25. [The diagnostic value of serum PABA determination in pancreatic disease and in relation to anticholinergic medication]. von Kleist D, Rössler W, Janisch HD, Hampel KE. Gastroenterol J; 1989 Dec; 49(3):108-12. PubMed ID: 2698170 [Abstract] [Full Text] [Related]
26. [The study of exocrine pancreas function by means of orally administered N-benzoyl-L-tyrosyl-praaminobenzoic acid (BT-PABA-test). Evaluation after 5 years clinical experience]. Lang C, Gyr K, Borer P, Kayasseh L, Stalder GA. Schweiz Med Wochenschr; 1980 Apr 05; 110(14):522-8. PubMed ID: 6966425 [Abstract] [Full Text] [Related]
27. [The PABA-peptide test: a method in diagnosis of exocrine pancreatic insufficiency (author's transl)]. Schneiber E, Burgislaus E. Med Klin; 1979 Jun 22; 74(25):1000-3. PubMed ID: 314038 [Abstract] [Full Text] [Related]
28. [Personal experience in studying the exocrine function of the pancreas using Spofagnost]. Bátovský M, Vavrecka A, Michelecková D, Brimichová G. Vnitr Lek; 1985 Jun 22; 31(6):595-601. PubMed ID: 3875926 [No Abstract] [Full Text] [Related]
29. [Screening of exocrine pancreatic function (author's transl)]. Stock KP, Schenk J, Schmack B, Domschke W. Dtsch Med Wochenschr; 1981 Jul 31; 106(31-32):983-7. PubMed ID: 6973459 [Abstract] [Full Text] [Related]
30. Measurement of extra-pancreatic secretory function by 13C-dipeptide breath test. Ishii Y, Kohno T, Ito A, Suzuki S, Kohno T, Takayama T, Asai S. Transl Res; 2007 Jun 31; 149(6):298-303. PubMed ID: 17543847 [Abstract] [Full Text] [Related]
31. [Pancreatic Function Diagnostant (PFD): a pancreatic exocrine function test with synthetic peptide, BT-PABA]. Kubo Y, Kuwahara S, Tanikawa K. Nihon Rinsho; 1980 Jun 31; 38(1):45-50. PubMed ID: 6993727 [No Abstract] [Full Text] [Related]
32. The PFD test for pancreatic disease patients. Miwa M, Kikuchi K, Senoue I, Watanabe H, Nomiyama T, Suzuki S, Harasawa S, Tani N, Miwa T, Sugita T. Tokai J Exp Clin Med; 1981 Jul 31; 6(3):309-13. PubMed ID: 6975509 [Abstract] [Full Text] [Related]
33. Tubeless pancreatic function tests used in combination for screening of pancreatic disease. Pap A, Berger Z, Varró V. Acta Med Hung; 1986 Jul 31; 43(1):39-43. PubMed ID: 3022227 [Abstract] [Full Text] [Related]
34. [PFD (pancreatic function diagnostant) test (exocrine pancreatic function test with oral loading of BTPABA)]. Kinugasa K, Hosoda S. Nihon Rinsho; 1979 Jun 29; Suppl():2447-8. PubMed ID: 315006 [No Abstract] [Full Text] [Related]
35. Exocrine pancreatic function test by a synthetic peptide. Harada H, Mishima K, Shundo T, Yamamoto N, Sasaki T, Hinofuji T, Hayashi T, Uchida Y, Kimura I. Am J Gastroenterol; 1979 Jan 29; 71(1):45-52. PubMed ID: 312010 [Abstract] [Full Text] [Related]
36. [Excretory pancreatic function: comparison of indirect function tests with the secretin-cholecystokinin test]. Wildgrube HJ, Schröter R, Classen M. Dtsch Med Wochenschr; 1982 Nov 19; 107(46):1751-5. PubMed ID: 7140556 [Abstract] [Full Text] [Related]
37. [Oral administration of a chymotrypsin-labile synthetic peptide, a new test for exocrine pancreatic function, and its diagnostic value in pancreatic diseases (author's transl)]. Takayama T, Hayakawa T, Noda A, Aoki I, Horiguchi Y, Yamazaki Y, Ito K, Naruse S, Kondo T, Iinuma Y. Nihon Naika Gakkai Zasshi; 1980 Apr 19; 69(4):447-53. PubMed ID: 6967099 [No Abstract] [Full Text] [Related]
38. Lack of accuracy of plasma alpha-amino nitrogen profiles as an indicator of exocrine pancreatic function both after continuous and bolus stimulation of the pancreas with secretin and cholecystokinin-pancreozymin. Lembcke B, Konle O, Duan LP, Caspary WF. Z Gastroenterol; 1994 Dec 19; 32(12):679-83. PubMed ID: 7871858 [Abstract] [Full Text] [Related]
39. [Exocrine pancreatic function test by N-benzoyl-L-tyrosyl-p-aminobenzoic acid (author's transl)]. Thienhaus R, Niederau C. Z Gastroenterol; 1979 Mar 19; 17(3):187-94. PubMed ID: 311979 [Abstract] [Full Text] [Related]
40. Tubeless tests of exocrine pancreatic function in patients with cystic fibrosis. Lamers CB. Neth J Med; 1992 Oct 19; 41(3-4):101-4. PubMed ID: 1470277 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]